Corcept Therapeutics (CORT) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94% |
| Dec 31, 2025 | 3.32% |
| Sep 30, 2025 | 0.33% |
| Jun 30, 2025 | 3.33% |
| Mar 31, 2025 | -0.99% |
| Dec 31, 2024 | -6.79% |
| Sep 30, 2024 | -10.43% |
| Jun 30, 2024 | -18.61% |
| Mar 31, 2024 | -17.06% |
| Dec 31, 2023 | -12.24% |
| Sep 30, 2023 | -12.72% |
| Jun 30, 2023 | -17.83% |
| Mar 31, 2023 | -29.98% |
| Dec 31, 2022 | -37.22% |
| Sep 30, 2022 | -39.45% |
| Jun 30, 2022 | -41.10% |
| Mar 31, 2022 | -45.62% |
| Dec 31, 2021 | -34.11% |
| Sep 30, 2021 | -49.82% |
| Jun 30, 2021 | -54.68% |
| Mar 31, 2021 | -55.71% |
| Dec 31, 2020 | -61.24% |
| Sep 30, 2020 | -63.72% |
| Jun 30, 2020 | -61.37% |
| Mar 31, 2020 | -51.94% |
| Dec 31, 2019 | -62.64% |
| Sep 30, 2019 | -53.96% |
| Jun 30, 2019 | -42.77% |
| Mar 31, 2019 | -33.78% |
| Dec 31, 2018 | -30.38% |
| Sep 30, 2018 | -25.31% |
| Jun 30, 2018 | -17.24% |
| Mar 31, 2018 | -9.00% |
| Dec 31, 2017 | 0.94% |
| Sep 30, 2017 | 5.86% |
| Jun 30, 2017 | -13.65% |
| Mar 31, 2017 | -4.36% |
| Dec 31, 2016 | -5.39% |
| Sep 30, 2016 | -0.84% |
| Jun 30, 2016 | 4.36% |
| Mar 31, 2016 | 7.20% |
| Dec 31, 2015 | -10.47% |
| Sep 30, 2015 | -4.70% |
| Jun 30, 2015 | -0.92% |